Biogen Idec Inc (BIIB)

Recent Material Events for Biogen Idec Inc
Date Description
Oct 25, 2012 The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subj
Oct 25, 2012 The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subj
Oct 09, 2012 On October 9, 2012, our Board of Directors amended our Second Amended and Restated Bylaws to replace a reference to Rule 14a-11 with a reference to other applicable rules and regulations under the Securities Exchange Act of 1934 and to shorten the ti
Jul 24, 2012 The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subj
Jun 13, 2012 At the 2012 Annual Meeting of Stockholders of Biogen Idec Inc. (Company) held on June 8, 2012 (Annual Meeting), stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (Charter Amendment) that design
May 01, 2012 The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subj
Mar 02, 2012 Gregory F. Covino is expected to join Biogen Idec Inc. as Vice President, Finance on April 2, 2012 and will be appointed Chief Accounting Officer, replacing Biogen Idec’s current Chief Accounting Officer, after the filing of Biogen Idec’s Q
Mar 02, 2012 Gregory F. Covino is expected to join Biogen Idec Inc. as Vice President, Finance on April 2, 2012 and will be appointed Chief Accounting Officer, replacing Biogen Idec’s current Chief Accounting Officer, after the filing of Biogen Idec’s Q
Feb 03, 2012 33 PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 34 Item 6. Selected Consolidated Financial Data
Feb 03, 2012 33 PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 34 Item 6. Selected Consolidated Financial Data